Research Article

Evaluation of the Reliability of Electronic Medical Record Data in Identifying Comorbid Conditions among Patients with Advanced Non-Small Cell Lung Cancer

Table 2

Measured reliability of algorithm (combination of programmatic queries and key word searches).

Electronic chart review groupTrue negatives (via chart review)False negatives (via chart review)Negative predictive value95% confidence interval

patients identified as negative via algorithm414360.920.89–0.94

Subgroup analyses of patients negative for comorbidities via algorithm

Group 1: Negative for all comorbidities ( )134160.890.83–0.94
Group 2: Negative for diabetes ( )4190.820.69–0.91
Group 3: Negative for cardiovascular disease ( )4730.940.83–0.99
Group 4: Negative for cerebrovascular disease ( )5001.000.93–1.00
Group 5: Negative for moderate/severe renal disease ( )4730.940.83–0.99
Group 6: Negative for liver disease ( )4910.950.89–0.99
Group 7: Negative for COPD ( )4640.920.81–0.98

COPD: chronic obstructive pulmonary disorder.